Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical eye-related health issues using advanced technology ...
An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering ...
Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion does not improve vision recovery at 30 days compared with oral aspirin, according to a study ...
Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...
In this expert perspective from Retina 2026, Sharon Fekrat, MD, FACS, FASRS, discusses a real-world retrospective analysis of the Vestrum Health Retina Database of patients with retinal vein occlusion ...
Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
Interesting Engineering on MSN
First-ever experimental gene therapy seeks to restore vision by rejuvenating eye neurons
Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...
Southern Living on MSN
Retinal vs. retinol: What's the difference?
Learn how to decode these anti-aging ingredients.
MedPage Today on MSN
Thrombolysis No Better Than Aspirin for Central Retinal Artery Occlusion
Vision recovery similar at 30 days, consistent with other recent randomized studies ...
Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...
A retinal tear is a small split or hole in the lining of the back of the eye. The condition is not painful and may not damage a person’s eyesight. However, a torn retina can progress to a retinal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results